Research Paper Volume 15, Issue 20 pp 11412—11447
Molecular characterization of ferroptosis in soft tissue sarcoma constructs a prognostic and immunotherapeutic signature through experimental and bioinformatics analyses
Figure 8. Construction of a prognostic nomogram and validation of the Fescore in multiple tumors. (A) ROC curve of Fescore for predicting the 1-year, 3- and 5-years survival of STS. (B) The prognostic nomogram based on gender, age, race, metastasis, margin status and Fescore for predicting the prognosis of STS. (C–E) The calibration curve of 1-year, 3- and 5-years survival of STS. (F, G) Validation of Fescore across 33 types of tumors.